James Shearer, John Sherman, Alex Wodak, Ingrid van Beek
31 May 2002
The illicit use of amphetamines continues to be a growing problem in many countries around the world, yet treatment responses remain in need of further development. This is particularly true with regards to pharmacotherapy for amphetamine dependence. In this Harm Reduction Digest four authors who bring together considerable research and clinical experience in this area describe the nature of amphetamine-related problems and consider the role of amphetamine agonists in substitution therapy for amphetamine dependence.
An ethnographic study of women and drug use in inner city neighborhoods in Kingston, Jamaica, revealed that cannabis is commonly used in conjunction with crack cocaine to minimize the undesirable effects of crack pipe smoking, specifically paranoia and weight loss.
In a confidential and authoritative memorandum to the INCB, UNODC legal experts argue that most harm reduction measures are in fact acceptable under the conventions. According to the Legal Affairs Section "it could easily be argued that the Guiding Principles of Drug Demand Reduction provide a clear mandate for the institution of harm reduction policies that, respecting cultural and gender differences, provide for a more supportive environment for drug users."
Recent developments in drug policy can be regarded as taking place in stages based on certain changeable paradigms: the abstinence paradigm, the medicalization paradigm and the acceptance paradigm. For the time being there seems to be a slow transition from the first to the latter, implying that elements of all three are presently active in a diversity of policies and strategies, differing between states and regions of the German federal state and the European Union as well as between different levels of drug policy and drug care.